We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » European Commission Planning Major Drug GMP Revisions
European Commission Planning Major Drug GMP Revisions
The European Commission will revise four sections of its good manufacturing practice guideline and add a new one, as it moves to harmonize GMPs with international standards and speed the path to mutual reliance with foreign regulators, a UK official says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor